Survival at 1, 3, and 5 years in diabetic and nondiabetic patients on hemodialysis

Iranian Journal of Kidney Diseases

Volumn 4, Issue 1, 2010, Pages 74-77

  Mousavi, Seyed Seifollah Beladi ^a   Hayati, Fatemeh ^a   Ansari, Mohammad Javad Alemzadeh ^a   Valavi, Ehsan ^a   Cheraghian, Bahman ^a   Shahbazian, Heshmatollah ^a   Golzari, Khadijeh ^a   Ghorbani, Ali ^a   Rashidi, Homira ^a   Payami, Peyman ^a   Ghaderian, Bahman ^a   Eideni, Esmaeel ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetic nephropathy; End stage renal disease; Hemodialysis; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SURVIVAL RATE;

ADULT; AGED; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; IRAN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS; SURVIVAL ANALYSIS;

EID: 75649098216     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. United State Renal Data System [homepage on the internet]. Incidence and prevalence of ESRD annual data report. Atlas of end stage renal disease in the United States. National Institute of Health. Available from: http://www.usrds.org/2009/view/default.asp
2. Tzamaloukas AH, Yuan ZY, Balaskas E, Oreopoulos DG. CAPD in end stage patients with renal disease due to diabetes mellitus - an update. Adv Perit Dial. 1992;8:185-91.
3. O'Donoghue D, Manos J, Pearson R, et al. Continuous ambulatory peritoneal dialysis and renal transplantation: a ten-year experience in a single center. Perit Dial Int. 1992;12:242, 5-9.
4. Murphy SW, Foley RN, Barrett BJ, et al. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int. 2000;57:1720-6.
5. Collins AJ, Hanson G, Umen A, Kjellstrand C, Keshaviah P. Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality. Am J Kidney Dis. 1990;15:422-32.
6. Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin DS. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis. 1990;15:451-7.
7. Iseki K, Kawazoe N, Osawa A, Fukiyama K. Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). Kidney Int. 1993;43:404-9.
8. Charra B, Calemard E, Ruffet M, et al. Survival as an index of adequacy of dialysis. Kidney Int. 1992;41:1286-91.
9. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med. 1981;305:1176-81.
10. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int. 1985;28:526-34.
11. Fenton S, Desmeules M, Copleston P, et al. Renal replacement therapy in Canada: a report from the Canadian Organ Replacement Register. Am J Kidney Dis. 1995;25:134-50.
12. Nishimura R, Dorman JS, Bosnyak Z, Tajima N, Becker DJ, Orchard TJ. Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: a report from the Allegheny County Registry. Am J Kidney Dis. 2003;42:117-24.
13. Chantrel F, Enache I, Bouiller M, et al. Abysmal prognosis of patients with type 2 diabetes entering dialysis. Nephrol Dial Transplant. 1999;14:129-36.
14. Perneger TV, Brancati FL, Whelton PK, Klag MJ. Endstage renal disease attributable to diabetes mellitus. Ann Intern Med. 1994;121:912-8.
15. Van Dijk PC, Jager KJ, Stengel B, Gronhagen-Riska C, Feest TG, Briggs JD. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int. 2005;67:1489-99.
16. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23 Suppl 2:B21-9.
17. Fliser D, Wagner KK, Loos A, Tsikas D, Haller H. Chronic angiotensin II receptor blockade reduces (intra)renal vascular resistance in patients with type 2 diabetes. J Am Soc Nephrol. 2005;16:1135-40.
18. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of followup. Arch Intern Med. 2004;164:1422-6.
19. Konner K. Primary vascular access in diabetic patients: an audit. Nephrol Dial Transplant. 2000;15:1317-25.
20. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med. 1994;331:854-60.
21. Becker BN, Odorico JS, Becker YT, et al. Simultaneous pancreas-kidney and pancreas transplantation. J Am Soc Nephrol. 2001;12:2517-27.
22. Mazzuchi N, Gonzalez-Martinez F, Carbonell E, Curi L, Fernandez-Cean J, Orihuela S. Comparison of survival for haemodialysis patients vs renal transplant recipients treated in Uruguay. Nephrol Dial Transplant. 1999;14:2849-54.